Related Experiment Video
Updated: Dec 14, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Anticoagulant protein S-New insights on interactions and functions
Magdalena Gierula1, Josefin Ahnström1
1Centre for Haematology, Imperial College London, London, UK.
Abstract:
Protein S is a critical regulator of coagulation that functions as a cofactor for the activated protein C (APC) and tissue factor pathway inhibitor (TFPI) pathways. It also has direct anticoagulant functions, inhibiting the intrinsic tenase and prothrombinase complexes. Through these functions, protein S regulates coagulation during both its initiation and its propagation phases. The importance of protein S in hemostatic regulation is apparent from the strong association between protein S deficiencies and increased risk for venous thrombosis. This is most likely because both APC and TFPIα are inefficient anticoagulants in the absence of any cofactors. The detailed molecular mechanisms involved in protein S cofactor functions remain to be fully clarified. However, recent advances in the field have greatly improved our understanding of these functions. Evidence suggests that protein S anticoagulant properties often depend on the presence of synergistic cofactors and the formation of multicomponent complexes on negatively charged phospholipid surfaces. Their high affinity binding to negatively charged phospholipids helps bring the anticoagulant proteins to the membranes, resulting in efficient and targeted regulation of coagulation. In this review, we provide an update on protein S and how it functions as a critical hemostatic regulator.
Insights
Protein S is a vital regulator of blood clotting, acting as a cofactor and directly inhibiting clot formation. Understanding its complex mechanisms is key to addressing thrombosis risks associated with protein S deficiency.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Protein S is an essential regulator of hemostasis, serving as a cofactor for activated protein C (APC) and tissue factor pathway inhibitor (TFPI).
- It possesses direct anticoagulant functions, inhibiting key complexes in the coagulation cascade, thus regulating both initiation and propagation phases.
- Protein S deficiency is strongly linked to an increased risk of venous thrombosis, highlighting its critical role in preventing excessive clotting.
Purpose of the Study:
- To provide an updated review of protein S functions in hemostatic regulation.
- To elucidate the molecular mechanisms underlying protein S cofactor activities.
- To highlight recent advances in understanding protein S's role in coagulation.
Main Methods:
- Review of existing literature and recent research findings on protein S.
- Analysis of molecular mechanisms and cofactor functions.
- Examination of the role of synergistic cofactors and phospholipid binding.
Main Results:
- Protein S regulates coagulation through cofactor roles and direct inhibition of enzymatic complexes.
- Its anticoagulant properties are often enhanced by synergistic cofactors and formation of complexes on phospholipid surfaces.
- High-affinity binding to phospholipids facilitates targeted regulation of coagulation.
Conclusions:
- Protein S is indispensable for effective hemostatic regulation, acting via multiple pathways.
- Recent findings reveal the importance of cofactor synergy and phospholipid interactions in protein S function.
- Further clarification of molecular mechanisms will advance our understanding of thrombosis and anticoagulation.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...

